Clinical use of magnetic resonance spectroscopy in tumor patients
Semmler, W.; Bachert-Baumann, P.; Gückel, F.; Lorenz, W.J.; Van Kaick, G.
Zeitschrift für Gastroenterologie. Verhandlungsband 24: 158-161
1989
ISSN/ISBN: 0172-8504 PMID: 2474936 Document Number: 344661
Document emailed within 1 workday
Related Documents
Sijens, P.E.; Bovee, W.M. 1988: In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology Cancer Research 48(19): 5610-5611Karczmar, G.S.; Arbeit, J.M.; Toy, B.J.; Speder, A.; Weiner, M.W. 1992: Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy Cancer Research 52(1): 71-76
Farooq Sheikh, A.Sibtain.; Mohamed, M.Adel. 2017: Magnetic resonance spectroscopy and magnetic resonance spectroscopic imaging in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A literature review Jpma. Journal of the Pakistan Medical Association 67(6): 912-916
Mueller-Klieser, W.; Schaefer, C.; Walenta, S.; Rofstad, E.K.; Fenton, B.M.; Sutherland, R.M. 1990: Assessment of tumor energy and oxygenation status by bioluminescence, nuclear magnetic resonance spectroscopy, and cryospectrophotometry Cancer Research 50(6): 1681-1685
Vine, W. 1990: Clinical diagnosis by nuclear magnetic resonance spectroscopy. if not now, when? Archives of Pathology and Laboratory Medicine 114(5): 453-462
Buckman, D.K.; Erickson, K.L.; Ross, B.D. 1987: Dietary fat modulation of murine mammary tumor metabolism studied by in vivo 31P-nuclear magnetic resonance spectroscopy Cancer Research 47(21): 5631-5636
Passariello, R.; Patrizio, G. 1991: Magnetic resonance spectroscopy. a useful clinical tool or a mere scientific curiosity? La Radiologia Medica 81(4): 385-395
Bakunovich, A.V.; Sinitsyn, V.E.; Mershina, E.A. 2014: Clinical use of proton magnetic resonance spectroscopy in brain tumors and adjacent tissues Vestnik Rentgenologii i Radiologii 1: 39-50
Singer, S.; Souza, K.; Thilly, W.G. 1995: Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study Cancer Research 55(22): 5140-5145
Nadal, L.; Leray, G.; Desbarats, C.; Darcel, F.; Bansard, J.Y.; Bondon, A.; de Certaines, J.D. 1997: Proton and phosphorus nuclear magnetic resonance spectroscopy of human brain tumor extracts with automatic data classification: a preliminary study Cellular and Molecular Biology 43(5): 659-673
Kuzniecky, R. 1999: Magnetic resonance spectroscopy in focal epilepsy: 31P and 1H spectroscopy Revue Neurologique (Paris) 155(6-7): 495-498
Hsu, Y.Y.; Chang, C.N.; Chu, N.S.; Chang, C.; Hsu, J.C. 1997: Proton magnetic resonance spectroscopy in patients with complex partial seizures Journal of the Formosan Medical Association 96(8): 593-598
Pozdniakov, A.V.; Kartashev, A.V.; Tiutin, L.A.; Vinogradov, V.M.; Pozharisskiĭ, K.M. 2008: Proton magnetic resonance spectroscopy in postoperative radiochemotherapy of patients with cerebral glioblastoma Voprosy Onkologii 54(2): 164-169
Papadopoulou, M.V.; Ji, M.; Bloomer, W.D. 2006: Novel fluorinated hypoxia-targeted compounds as Non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS) Anticancer Research 26(5a): 3253-3258
Viala, K.; Stievenart, J.L.; Cabanis, E.A.; Lyon-Caen, O.; Tourbah, A. 2001: Study with localized proton magnetic resonance spectroscopy of 31 multiple sclerosis lesions: correlations with clinical and MRI features Revue Neurologique (Paris) 157(1): 35-44
Jiang, Q.-s.; Jiang, T.; Jin, Z.; Feng, H.-l.; Zeng, Y.-w.; Li, J. 2005: The biochemical changes of hippocampus in patients before and after denture restoration: a preliminary 1H-magnetic resonance spectroscopy study Zhonghua Kou Qiang Yi Xue Za Zhi 40(3): 223-226
Gupta, R.K.; Saraswat, V.A.; Poptani, H.; Dhiman, R.K.; Kohli, A.; Gujral, R.B.; Naik, S.R. 1993: Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure American Journal of Gastroenterology 88(5): 670-674
Hsu, Y.Y.; Chang, C.N.; Chu, N.S.; Lim, K.E.; Chang, C.; Hsu, J.C. 2001: Lateralization and prognostic value of proton magnetic resonance spectroscopy in patients with intractable temporal lobe epilepsy Chang Gung Medical Journal 24(12): 768-778
Wolf, R.F.; van der Hoeven, J.A.; Kamman, R.L.; Busza, A.L.; Ploeg, R.J.; Sluiter, W.J.; Slooff, M.J. 1996: Tissue pH in cold-stored human donor livers preserved in University of Wisconsin solution. A noninavasive clinical study with 31P-magnetic resonance spectroscopy Transplantation 61(1): 66-70
Gückel, F.; Bachert-Baumann, P.; Semmler, W.; Lorenz, W.J.; Van Kaick, G. 1989: Principles of magnetic resonance spectroscopy Zeitschrift für Gastroenterologie. Verhandlungsband 24: 155-157